\-\ Texto\\:\\ \ \(0\)\
\-\ noncontributory\\.\ \(24\)\
\-\ urological\\ consultation\\ and\\ follow\\ up\\.\ \(0\)\
\-\ bladder\\ demonstrates\\ trabeculation\\ with\\ a\\ posterior\\ urethral\\ valve\\.\\ ureters\\ insert\\ into\\ diverticuli\\ bilaterally\\ and\\ dilitation\\ of\\ the\\ posterior\\ urethra\\ is\\ demonstrated\\.\ \(0\)\
\-\ posterior\\ urethral\\ valves\ \(12\)\
\-\ none\ \(204\)\
\-\ 19\\ month\\ old\\ with\\ h\\/o\\ hydronephrosis\\.\ \(1\)\
\-\ congenital\\ valvular\\ obstruction\\ in\\ the\\ posterior\\ urethra\\ in\\ males\\ is\\ an\\ important\\ cause\\ of\\ urinary\\ tract\\ obstruction\\.\\ \\ it\\ is\\ a\\ common\\ cause\\ of\\ end\\ stage\\ nephropathy\\ in\\ males\\.\\ \\ these\\ valves\\ obstruct\\ urinary\\ flow\\ during\\ micturition\\ leading\\ to\\ dilatation\\ and\\ elongation\\ of\\ the\\ posterior\\ urethra\\.\\ \\ secondary\\ obstructive\\ changes\\ occur\\ in\\ the\\ bladder\\,\\ ureters\\ and\\ kidneys\\.\\ \\ there\\ is\\ bladder\\ hypertrophy\\ and\\ trabeculation\\ with\\ the\\ development\\ of\\ diverticula\\ and\\ saccules\\.\ \(0\)\
\-\ vesicoureteral\\ reflux\\ presents\\ in\\ 50\\%\\ of\\ patients\\ with\\ this\\ anomaly\\ with\\ one\\ third\\ being\\ unilateral\\.\\ \\ dilatation\\ and\\ tortuosity\\ of\\ the\\ ureters\\ often\\ occur\\.\\ \\ renal\\ parenchyma\\ is\\ reduced\\ in\\ higher\\ grade\\ conditions\\.\\ \\ affected\\ kidneys\\ demonstrate\\ dysplasia\\ and\\ small\\ size\\.\\ \\ function\\ of\\ the\\ affected\\ kidney\\ is\\ decreased\\ varying\\ upon\\ severity\\.\\ \\ \ \(0\)\
\-\ posterior\\ urethral\\ valves\\ are\\ associated\\ with\\ higher\\ grade\\ obstructions\\ and\\ changes\\ in\\ the\\ upper\\ urinary\\ tracts\\,\\ kidneys\\ and\\ bladder\\.\\ \\ symptoms\\ include\\ oliguria\\,\\ poor\\ urinary\\ stream\\ or\\ urinary\\ retention\\.\\ \\ physical\\ exam\\ reveals\\ abdominal\\ distention\\ and\\ palpable\\ abdominal\\ masses\\.\\ \\ prenatal\\ diagnosis\\ is\\ made\\ with\\ ultrasound\\ demonstrating\\ hydronephrosis\\,\\ hydroureters\\,\\ bladder\\ wall\\ thickening\\ and\\ posterior\\ urethral\\ dilatation\\.\\ \\ initial\\ presentation\\ includes\\ urinary\\ tract\\ infections\\,\\ urosepsis\\,\\ urinary\\ retention\\,\\ hematuria\\,\\ or\\ renal\\ failure\\.\\ \\ \ \(0\)\
\-\ the\\ vesicourethrogram\\ is\\ the\\ preferred\\ examination\\.\\ \\ dilation\\ of\\ the\\ posterior\\ urethra\\,\\ \\ valves\\ are\\ visualized\\ as\\ radiolucent\\ lines\\ and\\ there\\ is\\ an\\ abrupt\\ transition\\ between\\ the\\ dilated\\ and\\ normal\\ posterior\\ urethra\\.\\ \\ \\ \\ ultrasonography\\ demonstrates\\ a\\ thickened\\ bladder\\ wasll\\ with\\ a\\ dilated\\ bilateral\\ renal\\ collecting\\ system\\.\ \(0\)\
\-\ prognosis\\ is\\ improved\\ with\\ any\\ mechanism\\ that\\ relieves\\ increased\\ pressure\\ in\\ the\\ urinary\\ system\\.\\ \\ examples\\ of\\ these\\ include\\,\\ unilateral\\ vur\\,\\ large\\ bladder\\,\\ diverticuli\\ of\\ the\\ calyces\\,\\ or\\ ascites\\ in\\ utero\\.\ \(0\)\
\-\ silverman\\,\\ f\\.\\ and\\ kuhn\\,\\ j\\.\\ \\ \\‚\\Ä\\úthe\\ genitourinary\\ tract\\ and\\ retroperitoneum\\.\\‚\\Ä\\ù\\ \\ caffey\\‚\\Ä\\ôs\\ pediatric\\ x\\-ray\\ diagnosis\\:\\ an\\ integrated\\ imaging\\ approach\\.\\ \\ 1993\\.\\ ninth\\ edition\\.\ \(0\)\
\-\ donnelly\\,\\ l\\.\\ \\‚\\Ä\\úfundamentals\\ of\\ pediatric\\ radiology\\.\\‚\\Ä\\ù\\ \\ 2001\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ urinary\\:\\ 0\\.333793369770083\ \(0\)\
\-\ urethra\\:\\ 0\\.27573682527799925\ \(0\)\
\-\ bladder\\:\\ 0\\.26209355158220227\ \(0\)\
\-\ posterior\\:\\ 0\\.22455359270219588\ \(0\)\
\-\ urethral\\:\\ 0\\.2138000438306821\ \(0\)\
\-\ valves\\:\\ 0\\.2138000438306821\ \(0\)\
\-\ and\\:\\ 0\\.159523760347955\ \(0\)\
\-\ ureters\\:\\ 0\\.15744684546984083\ \(0\)\
\-\ the\\:\\ 0\\.1444138174546113\ \(0\)\
\-\ trabeculation\\:\\ 0\\.13313118502695845\ \(0\)\
\-\ is\\:\\ 0\\.13213541598593545\ \(0\)\
\-\ kidneys\\:\\ 0\\.1246022600866235\ \(0\)\
\-\ tract\\:\\ 0\\.12126090682700603\ \(0\)\
\-\ dilatation\\:\\ 0\\.11816252449012438\ \(0\)\
\-\ diverticuli\\:\\ 0\\.11375919845060704\ \(0\)\
\-\ of\\:\\ 0\\.11330731951208456\ \(0\)\
\-\ retention\\:\\ 0\\.11300721639178156\ \(0\)\
\-\ in\\:\\ 0\\.108026908555236\ \(0\)\
\-\ males\\:\\ 0\\.09953582844951879\ \(0\)\
\-\ renal\\:\\ 0\\.09013958297257137\ \(0\)\
\-\ hydronephrosis\\:\\ 0\\.08955553691896125\ \(0\)\
\-\ unilateral\\:\\ 0\\.08831500564366492\ \(0\)\
\-\ higher\\:\\ 0\\.08764494534705569\ \(0\)\
\-\ pediatric\\:\\ 0\\.08637954737488442\ \(0\)\
\-\ with\\:\\ 0\\.08503126545637005\ \(0\)\
\-\ affected\\:\\ 0\\.07936864954605183\ \(0\)\
\-\ saccules\\:\\ 0\\.07716196959490898\ \(0\)\
\-\ vesicourethrogram\\:\\ 0\\.07716196959490898\ \(0\)\
\-\ wasll\\:\\ 0\\.07716196959490898\ \(0\)\
\-\ micturition\\:\\ 0\\.07373238132727598\ \(0\)\
\-\ oliguria\\:\\ 0\\.07373238132727598\ \(0\)\
\-\ relieves\\:\\ 0\\.07373238132727598\ \(0\)\
\-\ system\\:\\ 0\\.07361916983008374\ \(0\)\
\-\ hydroureters\\:\\ 0\\.0712990497267039\ \(0\)\
\-\ occur\\:\\ 0\\.0709705206472851\ \(0\)\
\-\ urological\\:\\ 0\\.06941161110305538\ \(0\)\
\-\ silverman\\:\\ 0\\.06941161110305538\ \(0\)\
\-\ grade\\:\\ 0\\.06939164187667861\ \(0\)\
\-\ dilated\\:\\ 0\\.0691147648149272\ \(0\)\
\-\ urosepsis\\:\\ 0\\.06786946145907091\ \(0\)\
\-\ kuhn\\:\\ 0\\.06786946145907091\ \(0\)\
\-\ ninth\\:\\ 0\\.06786946145907091\ \(0\)\
\-\ obstruction\\:\\ 0\\.0675925369321144\ \(0\)\
\-\ stream\\:\\ 0\\.06656559251347922\ \(0\)\
\-\ caffey\\:\\ 0\\.06656559251347922\ \(0\)\
\-\ donnelly\\:\\ 0\\.06656559251347922\ \(0\)\
\-\ cause\\:\\ 0\\.06574004104057517\ \(0\)\
\-\ obstruct\\:\\ 0\\.06543612985849882\ \(0\)\
\-\ obstructions\\:\\ 0\\.06543612985849882\ \(0\)\
\-\ vur\\:\\ 0\\.06543612985849882\ \(0\)\
\-\ integrated\\:\\ 0\\.06543612985849882\ \(0\)\
\-\ insert\\:\\ 0\\.06443987319143792\ \(0\)\
\-\ elongation\\:\\ 0\\.062006541590865834\ \(0\)\
\-\ tortuosity\\:\\ 0\\.06132950791852945\ \(0\)\
\-\ nephropathy\\:\\ 0\\.06011910296721731\ \(0\)\
\-\ examples\\:\\ 0\\.06011910296721731\ \(0\)\
\-\ valvular\\:\\ 0\\.05857695332323284\ \(0\)\
\-\ changes\\:\\ 0\\.05832036091390353\ \(0\)\
\-\ include\\:\\ 0\\.05741640974880001\ \(0\)\
\-\ dilitation\\:\\ 0\\.05687959922530352\ \(0\)\
\-\ tracts\\:\\ 0\\.05650360819589078\ \(0\)\
\-\ genitourinary\\:\\ 0\\.05650360819589078\ \(0\)\
\-\ fundamentals\\:\\ 0\\.05650360819589078\ \(0\)\
\-\ calyces\\:\\ 0\\.056143621722660755\ \(0\)\
\-\ an\\:\\ 0\\.05535171005666161\ \(0\)\
\-\ ultrasonography\\:\\ 0\\.05514736505559985\ \(0\)\
\-\ utero\\:\\ 0\\.05454293616741794\ \(0\)\
\-\ these\\:\\ 0\\.05449333384022718\ \(0\)\
\-\ abrupt\\:\\ 0\\.052952314153420534\ \(0\)\
\-\ abdominal\\:\\ 0\\.052778215237213814\ \(0\)\
\-\ radiolucent\\:\\ 0\\.052714033455027766\ \(0\)\
\-\ vesicoureteral\\:\\ 0\\.05248228182328028\ \(0\)\
\-\ diverticula\\:\\ 0\\.052256710977645594\ \(0\)\
\-\ preferred\\:\\ 0\\.05121113402263018\ \(0\)\
\-\ edition\\:\\ 0\\.05121113402263018\ \(0\)\
\-\ varying\\:\\ 0\\.0506406883276857\ \(0\)\
\-\ transition\\:\\ 0\\.05045878012490281\ \(0\)\
\-\ or\\:\\ 0\\.0503557618878305\ \(0\)\
\-\ diagnosis\\:\\ 0\\.05002473161269479\ \(0\)\
\-\ ascites\\:\\ 0\\.049767914224759395\ \(0\)\
\-\ consultation\\:\\ 0\\.04868001629921286\ \(0\)\
\-\ demonstrates\\:\\ 0\\.04848037192588192\ \(0\)\
\-\ lines\\:\\ 0\\.048115913615753486\ \(0\)\
\-\ severity\\:\\ 0\\.047587091089465454\ \(0\)\
\-\ prenatal\\:\\ 0\\.047587091089465454\ \(0\)\
\-\ distention\\:\\ 0\\.04685111358682269\ \(0\)\
\-\ reduced\\:\\ 0\\.04628322214387376\ \(0\)\
\-\ approach\\:\\ 0\\.04628322214387376\ \(0\)\
\-\ 2001\\:\\ 0\\.04554724464123099\ \(0\)\
\-\ hypertrophy\\:\\ 0\\.04544714400053879\ \(0\)\
\-\ mechanism\\:\\ 0\\.04544714400053879\ \(0\)\
\-\ collecting\\:\\ 0\\.04525042803157988\ \(0\)\
\-\ obstructive\\:\\ 0\\.04487021096889461\ \(0\)\
\-\ valve\\:\\ 0\\.0442433756956393\ \(0\)\
\-\ anomaly\\:\\ 0\\.04415750282183246\ \(0\)\
\-\ conditions\\:\\ 0\\.04407249300658654\ \(0\)\
\-\ noncontributory\\:\\ 0\\.042964202841807526\ \(0\)\
\-\ leading\\:\\ 0\\.042890329835832096\ \(0\)\
\-\ improved\\:\\ 0\\.042817096431007784\ \(0\)\
\-\ hematuria\\:\\ 0\\.042672504783246946\ \(0\)\
\-\ infections\\:\\ 0\\.04260112541096263\ \(0\)\
\-\ end\\:\\ 0\\.04246014872390314\ \(0\)\
\-\ dilation\\:\\ 0\\.04246014872390314\ \(0\)\
\-\ prognosis\\:\\ 0\\.04246014872390314\ \(0\)\
\-\ reflux\\:\\ 0\\.04178849400590955\ \(0\)\
\-\ important\\:\\ 0\\.040871524207947596\ \(0\)\
\-\ poor\\:\\ 0\\.0406994829125758\ \(0\)\
\-\ thickened\\:\\ 0\\.0406994829125758\ \(0\)\
\-\ development\\:\\ 0\\.03988815163388661\ \(0\)\
\-\ demonstrating\\:\\ 0\\.0397856242522743\ \(0\)\
\-\ parenchyma\\:\\ 0\\.039195263401296254\ \(0\)\
\-\ function\\:\\ 0\\.0390538940032578\ \(0\)\
\-\ stage\\:\\ 0\\.0384237214226327\ \(0\)\
\-\ there\\:\\ 0\\.038396908963357755\ \(0\)\
\-\ 19\\:\\ 0\\.03820957313838147\ \(0\)\
\-\ upon\\:\\ 0\\.03795955280532276\ \(0\)\
\-\ visualized\\:\\ 0\\.037676906755895044\ \(0\)\
\-\ includes\\:\\ 0\\.03751953653432372\ \(0\)\
\-\ made\\:\\ 0\\.03721331647132056\ \(0\)\
\-\ dysplasia\\:\\ 0\\.03695417656280272\ \(0\)\
\-\ third\\:\\ 0\\.03673820554275755\ \(0\)\
\-\ pressure\\:\\ 0\\.03673820554275755\ \(0\)\
\-\ reveals\\:\\ 0\\.0367027404785617\ \(0\)\
\-\ failure\\:\\ 0\\.03663225335882333\ \(0\)\
\-\ are\\:\\ 0\\.036617226215231\ \(0\)\
\-\ congenital\\:\\ 0\\.034667951373030366\ \(0\)\
\-\ kidney\\:\\ 0\\.03389726555160414\ \(0\)\
\-\ palpable\\:\\ 0\\.03389726555160414\ \(0\)\
\-\ 50\\:\\ 0\\.0336964631143531\ \(0\)\
\-\ being\\:\\ 0\\.03362237441801495\ \(0\)\
\-\ presentation\\:\\ 0\\.03321437222858729\ \(0\)\
\-\ masses\\:\\ 0\\.03284755462283334\ \(0\)\
\-\ thickening\\:\\ 0\\.03282514823775993\ \(0\)\
\-\ size\\:\\ 0\\.032669943783815075\ \(0\)\
\-\ initial\\:\\ 0\\.03236782576037776\ \(0\)\
\-\ bilaterally\\:\\ 0\\.03217915462014417\ \(0\)\
\-\ flow\\:\\ 0\\.032137793142033\ \(0\)\
\-\ often\\:\\ 0\\.031483005899177706\ \(0\)\
\-\ between\\:\\ 0\\.03135039660311548\ \(0\)\
\-\ any\\:\\ 0\\.03118289795308326\ \(0\)\
\-\ examination\\:\\ 0\\.030875285674552472\ \(0\)\
\-\ during\\:\\ 0\\.03056132943306099\ \(0\)\
\-\ decreased\\:\\ 0\\.02988693036763549\ \(0\)\
\-\ ultrasound\\:\\ 0\\.029761385867419735\ \(0\)\
\-\ demonstrated\\:\\ 0\\.02965304250518616\ \(0\)\
\-\ month\\:\\ 0\\.029350924481748846\ \(0\)\
\-\ wall\\:\\ 0\\.029350924481748846\ \(0\)\
\-\ secondary\\:\\ 0\\.02859888631986649\ \(0\)\
\-\ one\\:\\ 0\\.027625288132519323\ \(0\)\
\-\ common\\:\\ 0\\.027363175723893005\ \(0\)\
\-\ patients\\:\\ 0\\.02714316372681145\ \(0\)\
\-\ symptoms\\:\\ 0\\.026399569469562144\ \(0\)\
\-\ none\\:\\ 0\\.02636822265634442\ \(0\)\
\-\ physical\\:\\ 0\\.026162161176452904\ \(0\)\
\-\ increased\\:\\ 0\\.026091209486684443\ \(0\)\
\-\ follow\\:\\ 0\\.026010843985021594\ \(0\)\
\-\ bilateral\\:\\ 0\\.025931234875771012\ \(0\)\
\-\ upper\\:\\ 0\\.025783957700212395\ \(0\)\
\-\ into\\:\\ 0\\.02564877482756197\ \(0\)\
\-\ associated\\:\\ 0\\.025431274498772114\ \(0\)\
\-\ imaging\\:\\ 0\\.025356914411778498\ \(0\)\
\-\ demonstrate\\:\\ 0\\.02508374517863171\ \(0\)\
\-\ small\\:\\ 0\\.024888883242212785\ \(0\)\
\-\ it\\:\\ 0\\.024698409564855913\ \(0\)\
\-\ exam\\:\\ 0\\.024288984591094343\ \(0\)\
\-\ large\\:\\ 0\\.024175555998687853\ \(0\)\
\-\ up\\:\\ 0\\.023867368885441494\ \(0\)\
\-\ presents\\:\\ 0\\.023210654998490097\ \(0\)\
\-\ that\\:\\ 0\\.02093861335885185\ \(0\)\
\-\ normal\\:\\ 0\\.019700078845377077\ \(0\)\
\-\ as\\:\\ 0\\.0193836659521465\ \(0\)\
\-\ this\\:\\ 0\\.016579507790323276\ \(0\)\
\-\ old\\:\\ 0\\.014280006667716286\ \(0\)\
\-\ to\\:\\ 0\\.01206236075412044\ \(0\)\
